Results 21 to 30 of about 567,985 (207)

Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes [PDF]

open access: yesAnnals of Geriatric Medicine and Research, 2021
Background Digoxin is used to control heart rate in patients with heart failure (HF) and atrial fibrillation (AF). However, its use is often limited in older patients, as they are prone to digoxin toxicity. This study aimed to determine the prevalence of
Noppaket Singkham   +4 more
doaj   +1 more source

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment [PDF]

open access: yesOpen Veterinary Journal, 2022
Background: Atrial fibrillation (AF) is the most common arrhythmia in dogs, most frequently diagnosed as chronic AF associated with a structural heart disease.
Antonella Colella   +5 more
doaj   +1 more source

Correlation between Serum Digoxin Concentration and Impaired Renal or/and Hepatic Functions in Cardiac Patients [PDF]

open access: yesAin Shams Journal of Forensic Medicine and Clinical Toxicology, 2013
Digitalis toxicity is characterized by gastrointestinal, neurologic and non-specific cardiac manifestations with striking similarities to the clinical picture of primary congestive heart failure (CHF) making diagnosis of chronic digitalis toxicity in ...
Rania Abdel-Rahman   +2 more
doaj   +1 more source

Ten years of experience in treating patients with digoxin toxicity without the use of Digoxin Fab antibodies [PDF]

open access: yes, 2021
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are recommended to be used in patients with cardiac symptoms of digoxin toxicity,
Meamar, Rokhsareh   +7 more
core   +1 more source

Digoxin Toxicity [PDF]

open access: yesArchives of Internal Medicine, 1998
Serum digoxin concentrations (SDCs) are frequently sampled before completion of drug distribution. If elevated, these concentrations may be misinterpreted, potentially leading to a misdiagnosis of digoxin toxicity.To determine the frequency of elevated SDCs (>2.6 nmol/L [>2.0 ng/mL]) obtained at appropriate postdosing intervals and to evaluate the ...
K M, Williamson   +7 more
openaire   +2 more sources

Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study

open access: yesFrontiers in Pharmacology, 2023
Background: Adverse effects of intravenous digoxin vary from patients and disease status, which should be closely monitored.Aims: To explore the safety profile of intravenous digoxin in acute heart failure with reduced ejection fraction (HFrEF) among ...
Xintian Liu   +7 more
doaj   +1 more source

Clinical signs and symptoms of toxic serum digoxin levels in neonates

open access: yesThe Turkish Journal of Pediatrics, 2019
Digoxin is widely used in the treatment of congestive heart failure and some arrhythmias. Digoxin toxicity may occur easily because digoxin has a narrow therapeutic index.
Mehmet Mutlu   +4 more
doaj   +1 more source

The changing pattern of toxicity of digoxin [PDF]

open access: yesPostgraduate Medical Journal, 1981
Summary Toxicity to digoxin was monitored in 437 consecutive recipients in a comprehensive drug surveillance programme, Adverse reactions developed in 19.5% and, in contrast to previous reports, were generally of a relatively benign nature.
D A, Henry   +3 more
openaire   +2 more sources

Digoxin toxicity presenting as encephalopathy [PDF]

open access: yesPostgraduate Medical Journal, 1996
Summary We describe two cases of digoxin toxicity presenting with clinical and electroencephalographic evidence of encephalopathy without other features of digoxin toxicity.
J R, Greenaway   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy